维普中文期刊产品整合服务
23篇 您的检索式:作者名="Ponto KA"
    题名 作者 年代 出处 被引量
1The tale of radioiodine and Graves' orbitopathy显示文摘Ponto KA Zang S Kahaly GJ 2010Thyroid2010,20,7:1
2Clinical review: Intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity显示文摘Zang S Ponto KA Kahaly GJ 2011J Clin Endocrinol Metab2011,96,2:1
3Clinical review:intravenous glucocor-ticoids for Graves' orbitopathy : efficacy and morbidity 显示文摘Zang S Ponto KA Kahaly GJ 2011J Clin En- docrinol Metab2011,96,:1
4Quality of life in a german graves orbitopathy population显示文摘Ponto KA Hommel G Pitz S 0,,03:1
5Autoimmune thyrotoxicosis:diagnostic chal- lenges显示文摘Ponto KA Kahaly GJ 2012Am J Med2012,125,9:1
6Clinical review: intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity 显示文摘Zang S Ponto KA Kahaly GJ 2011J Clin Endocrinol Metab2011,96,:1
7Intravenous glucocorticoids for Graves, orbitopathy: efficacy and morbidity显示文摘Zang S Ponto KA Kahaly GJ 2011J Clin Endocrinol Metab2011,96,2:1
8A novel thyroid stimulating bioassay is a functional indicator of activity and severity of Graves' orbitopathy 显示文摘Lytton SD Ponto KA Kanitz M 2010J Clin Endocrinol Metab2010,95,:1
9Intravenous Glucocorticoids for Graves;Orbitopathy: Efficacy and Morbidity 显示文摘Zang S Ponto KA Kahaly GJ 2011J Clin Endocrinol Metab2011,96,2:1
10Myopia and level of education: results from the Gutenberg Health Study显示文摘Mirshahi A Ponto KA Hoehn R Zwiener I Zeller T Lackner K et at 2014Ophthalmology2014,121,10:1
11Intravenous glucocortieoids for Graves' Orbitopathy : efficacy and morbidity显示文摘Zang S Ponto KA Kahaly GJ 2011J Clin Endocrinol Metab2011,96,2:1
12Myopia and level of education: results from the gutenberg health study显示文摘Mirshahi A Ponto KA Hoehn R 2014Ophthalmology2014,121,10:1
13The tale of radioiodine and Graves' orbitopathy显示文摘Ponto KA Zang S Kahaly GJ 2010Thyroid2010,20,7:1
14Chnical Relevance of Thyroid- Stimulating Immunoglobulins in Graves Ophthalmopathy显示文摘Ponto KA Kanitz M Olivo PD Ophthalmolog0,118,11:1
15Intravenous glucocorticoids for Graves′ orbitopathy: efficacy and morbidity显示文摘Zang S Ponto KA Kahaly GJ 2011J Clin Endocrinol Metab2011,96,:1
16Intravenous glucocorticoids for graves' orbitopathy:efficacy and morbidity显示文摘Zang S Ponto KA Kahaly GJ 2011J Clin Endocrinol Metab2011,96,2:1
17A novel thyroid stimulat- ing immunoglobulin bioassay is a functional indicator of activi- ty and severity of Graves' orbitopathy 显示文摘Lytton SD Ponto KA Kanitz M 2010J Clin Endocrinol Metab2010,95,5:1
18Clinical review: Intrave- nous glucocorticoids for Graves' orbitopathy: efficacy and morbidity显示文摘Zang S Ponto KA Kahaly GJ 2011J Clin Endocrinol Metab2011,96,:1
19Quality of life in a German graves orbitopathy population 显示文摘Ponto KA Hommel G Pitz S 2011Am J Ophthalmol2011,152,3:1
20Current management of endocrine orbitopathy 显示文摘Ponto KA Kahaly GJ 2008Med Klin(Munich)2008,103,10:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费